戴青, 高自清. 玻璃体腔连续注射康柏西普治疗湿性年龄相关性黄斑变性短期疗效观察[J]. 中华解剖与临床杂志, 2018, 23(2): 166-168.
Dai Qing, Gao Ziqing. Observation of short-term efficacy of continuous intravitreal injection of conbercept for the treatment of wAMD. Chinese Journal of Anatomy and Clinics, 2018, 23(2): 166-168.
Bourne RR, Jonas JB, Flaxman SR, et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010[J]. Br J Ophthalmol, 2014, 98(5): 629-638. DOI:10.1136/bjophthalmol-2013-304033
Haller JA. Current anti-vascular endothelial growth factor dosing regimens: benefits and burden [J]. Ophthalmology, 2013, 120(5 Suppl): S3-S7. DOI:10.1016/j.ophtha.2013.01.057
[7]
Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD[J]. Eye (Lond), 2015, 29(10): 1397-1398. DOI:10.1038/eye.2015.159
[8]
Campochiaro PA, Nguyen QD, Shah SM, et al. Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial[J]. Hum Gene Ther, 2006, 17(2): 167-176. DOI:10.1089/hum.2006.17.167
Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis[J]. Lancet Glob Health, 2014, 2(2): e106-e116. DOI:10.1016/S2214-109X(13)70145-1
[11]
Seiple W, Rosen RB, Garcia PM. Abnormal fixation in individuals with age-related macular degeneration when viewing an image of a face[J]. Optom Vis Sci, 2013, 90(1): 45-56. DOI:10.1097/OPX.0b013e3182794775
[12]
Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group[J]. Arch Ophthalmol, 1994, 112(4): 489-499
2018, Vol. 23 
